SCHEMBL7922593

SCHEMBL7922593

N#Cc1ccc(-c2ccc(CCC(CCCc3ccccc3)C(=O)O)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 2/20 0.56
MMP13 P45452 2/20 0.56
MMP2 P08253 1/20 0.53
MMP3 P08254 1/20 0.53
GRIK1 P39086 1/20 0.50
PRSS1 P07477 1/20 0.47
CTSG P08311 1/20 0.47
CTRB1 P17538 1/20 0.47
CMA1 P23946 1/20 0.47
ABCB1 P08183 1/20 0.47
HPGD P15428 1/20 0.47
ABCG2 Q9UNQ0 1/20 0.47
TSHR P16473 1/20 0.47
HSD17B10 Q99714 1/20 0.47
FOLH1 Q04609 1/20 0.46
MME P08473 1/20 0.45
FAAH O00519 1/20 0.45
FDFT1 P37268 2/20 0.45
CYP19A1 P11511 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7932591 0.89 MMP12 (0.63) MMP12MMP13MMP2MMP3GRIK1
SCHEMBL1862879 0.89 PRSS1 (0.47) MMP12MMP13MMP2MMP3GRIK1
SCHEMBL7928277 0.88 MMP12 (0.64) MMP12MMP13MMP2MMP3GRIK1
SCHEMBL1861903 0.87 GRIK1 (0.59) MMP12MMP13MMP2MMP3GRIK1
SCHEMBL3466543 0.87 MMP12 (0.51) MMP12MMP13MMP2MMP3PRSS1
SCHEMBL7924568 0.86 MMP12 (0.48) MMP12MMP13MMP2MMP3PRSS1
SCHEMBL3466957 0.84 FFAR1 (0.51) MMP2MMP3GRIK1MMEFAAH
SCHEMBL1860416 0.83 GRIK1 (0.68) MMP2MMP3GRIK1FOLH1
SCHEMBL7922577 0.82 PPARG (0.56) MMP12MMP13MMP2MMP3GRIK1
SCHEMBL7924101 0.82 GRIK1 (0.54) MMP12MMP13MMP2MMP3GRIK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO disclosed